All filters
Abstracts
Does Dolutegravir causes weight gain: a retrospective observational cohort study from Lusaka, Zambia
D. Mwamba Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Dolutegravir- versus low-dose Efavirenz-based regimen for the initial treatment of HIV-1 infection in Cameroon: 96-week results of the ANRS 12313 – NAMSAL trial
C. Kouanfack Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Effectiveness of male Strategy (MS) in HIV case identification and linkage of MLHIV to treatment in Cameroon.
E. Njemkerk Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Switching to DTG/3TC Fixed-Dose Combination (FDC) Is Non-inferior to Continuing a TAF-Based Regimen Through 48 Weeks: Subgroup Analyses From the TANGO Study
J. van Wyk Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Optimizing HIV Treatment among Children in Mozambique
M. Tomo De Deus Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Impact of community resource persons and mobile phone technology on return to HIV care among loss to follow up HIV clients in 104 HIV facilities in Uganda
A. Mugisa Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
U=U - Catalyst or Barrier for Men's Engagement in ART? Stakeholder Views from Blantyre, Malawi
A. Berner-Rodoreda Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Patient-reported reasons for missed appointments among ART patients in South Africa
C. Biedron Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Evaluation of Second Line Antiretroviral Programmatic and Treatment Outcomes in Mozambique between 2015-2017
A. Muteerwa Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Minimal cross-resistance to tenofovir in children and adolescents failing abacavir-based ART makes them eligible for tenofovir-lamivudine-dolutegravir treatment.
K. Steegen Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Factors associated with unsuppressed viral load among patients enrolled in the Community HIV Care Program in Botswana. A retrospective cross-sectional study.
C. Trapence Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Improving retention in ART care using Call-2Care© approach: A snapshot from Defence Forces of Zambia (DFZ)
P. Makelele Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
The effect of home-based care in achieving viral load coverage in two high volume facilities in Akwa Ibom state, Nigeria
O. Toyo Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Improving linkage to antiretroviral therapy using a peer attachment model in selected facilities in the Southern Highland Zone of Tanzania
A. Ngwalle Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Acceptability of Quadrimune, a new Abacavir/Lamivudine/Lopinavir/Ritonavir paediatric fixed dose combination
V. Musiime Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Limited increase in primary HIV‐1C drug resistance mutations in treatment naïve individuals in Ethiopia
K. Ghezehegn Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Comparative study on the liver profile of HIV positive pregnant women and HIV positive non-pregnant women attending the Bamenda Regional Hospital, Cameroon
M. Alice Enekegbe Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Virological suppression among HIV infected adolescents and youths receiving ART in the National teaching and referral hospital in Kenya.
J. Kangethe Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
HIV-1C proviral DNA for detection of drug resistance mutations
K. Ghezehegn Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Zimbabwe’s National Third-Line Antiretroviral Therapy Program: Cohort Description and Treatment Outcomes
C. Chimbetete Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020